Northrop Grumman, US6668071029

Northrop Grumman stock: 2027 outlook points to faster growth

Published on 10/30/2026 at 11:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Northrop Grumman stock enters 2027 with a record backlog and a broader growth path. Management points to higher sales across all four segments.

Growth outlook and backlog

  • Northrop Grumman entered 2027 with a record backlog of 110 billion US dollars and a 1.5 book-to-bill ratio.
  • Management expects higher sales across all four operating segments and faster growth beyond 2027.
  • B-21 production, Sentinel, international awards and weapons programs remain important execution factors.
Northrop Grumman, US6668071029, Illustration mit AI erstellt.

Northrop Grumman's management used its third-quarter earnings call on October 20 to outline a faster growth path for 2027. The company expects sales to rise by 5% to 7% next year, according to The Motley Fool.

Northrop Grumman stock traded at 503.90 euros on Lang & Schwarz at 11:44 a.m. CET on Friday, October 30. The quote reflects the company's European trading line and is not presented as a comparison with an Xetra close.

Backlog supports multiyear visibility

Northrop Grumman ended the quarter with a record backlog of 110 billion US dollars. Chief Executive Kathy Warden said quarterly bookings exceeded billed work, producing a book-to-bill ratio of 1.5. The backlog gives the defense contractor visibility across long-cycle programs, although converting contracted work into sales still depends on production and delivery schedules.

Chief Financial Officer John Greene said the 2027 sales outlook covers all four operating segments. Management expects segment operating income to grow faster than sales and sees a 10 to 20 basis-point improvement in the segment margin against the midpoint of its 2026 outlook.

Programs drive the next phase

The growth plan rests on higher production rates for major defense programs, including the B-21 Raider. Management also identified the Sentinel program, shipbuilding support, the expanding weapons portfolio and international sales as potential contributors. The timing of contract awards, appropriations and production scaling could determine where results land within the range.

Northrop Grumman also expects capital spending of about 2.1 billion US dollars in 2027, while projecting adjusted free cash flow of 3.3 billion to 3.7 billion US dollars. The spending is intended to support additional capacity, including the planned B-21 production ramp.

Management said growth could accelerate again in 2028, but it did not commit to a specific 2028 rate. For investors, the key question is whether the backlog converts into revenue at the expected pace without eroding margins through program execution or higher production costs.

Investors can follow the real-time quote of Northrop Grumman stock during the trading session.

U.S. equities can be followed in the S&P 500 market overview.

For more coverage, see More news and analyses on Northrop Grumman stock.

Northrop Grumman Corporation

  • Company: Northrop Grumman Corporation
  • ISIN: US6668071029
  • Ticker: NOC
  • Lang & Schwarz quote: 503.90 euros on Friday, October 30, 2026, at 11:44 a.m. CET
  • 2027 sales outlook: 5% to 7% growth
  • 2027 adjusted free cash flow outlook: 3.3 billion to 3.7 billion US dollars
Disclaimer...
en | US6668071029 | NORTHROP GRUMMAN | boerse | 70434256 |